The upcoming patent expiry of semaglutide on March 20 in India is paving the way for a surge in affordable... Read more
Category: Uncategorized
Argentina officially concludes withdrawal from World Health Organization
The Argentine government has confirmed the termination of its membership in the World Health Organization (WHO). This move signifies a... Read more
SK pharmteco’s U.S. facility successfully clears FDA regulatory inspection
SK pharmteco has announced the successful completion of a regulatory inspection conducted by the U.S. Food and Drug Administration (FDA)... Read more
Green Elephant Biotech unveils Archimedes One to streamline cell therapy manufacturing
Green Elephant Biotech has introduced Archimedes One, the pioneer in a new category of "Dynamic Adherent Bioreactors." The system is... Read more
Oxford Biomedica signs viral vector licensing deal with Australia’s VVMF
Oxford Biomedica (OXB), a prominent CDMO specializing in cell and gene therapies, has finalized a licensing and option agreement with... Read more
Samsung Bioepis and Sandoz ink global licensing deal for five biosimilar candidates
Samsung Bioepis and Sandoz have entered into a global licensing, development, and commercialization agreement for up to five biosimilar candidates.... Read more
Pfizer’s next-generation breast cancer therapy shows promising clinical results
Pfizer has reached a significant milestone in its oncology expansion strategy with positive data from a clinical trial of its... Read more
Federal court halts controversial shifts in U.S. vaccine policy
A federal judge has issued a temporary injunction against several major policy changes directed by Health and Human Services (HHS)... Read more
Chinese biotech startup raises $69M to advance next-gen immunotherapy
Excalipoint Therapeutics, a Shanghai-based biotech newcomer, officially launched with $68.7 million in financing. The company focuses on developing multi-specific antibody... Read more









